Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging
Background and purpose The aim was to define the radiological picture of facioscapulohumeral muscular dystrophy 2 (FSHD2) in comparison with FSHD1 and to explore correlations between imaging and clinical/molecular data. Methods Upper girdle and/or lower limb muscle magnetic resonance imaging scans o...
Gespeichert in:
Veröffentlicht in: | European journal of neurology 2020-12, Vol.27 (12), p.2604-2615 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2615 |
---|---|
container_issue | 12 |
container_start_page | 2604 |
container_title | European journal of neurology |
container_volume | 27 |
creator | Giacomucci, G. Monforte, M. Diaz‐Manera, J. Mul, K. Fernandez Torrón, R. Maggi, L. Marini Bettolo, C. Dahlqvist, J. R. Haberlova, J. Camaño, P. Gros, M. Tartaglione, T. Cristiano, L. Gerevini, S. Calandra, P. Deidda, G. Giardina, E. Sacconi, S. Straub, V. Vissing, J. Van Engelen, B. Ricci, E. Tasca, G. |
description | Background and purpose
The aim was to define the radiological picture of facioscapulohumeral muscular dystrophy 2 (FSHD2) in comparison with FSHD1 and to explore correlations between imaging and clinical/molecular data.
Methods
Upper girdle and/or lower limb muscle magnetic resonance imaging scans of 34 molecularly confirmed FSHD2 patients from nine European neuromuscular centres were analysed. T1‐weighted and short‐tau inversion recovery (STIR) sequences were used to evaluate the global pattern and to assess the extent of fatty replacement and muscle oedema.
Results
The most frequently affected muscles were obliquus and transversus abdominis, semimembranosus, soleus and gluteus minimus in the lower limbs; trapezius, serratus anterior, latissimus dorsi and pectoralis major in the upper girdle. Iliopsoas, popliteus, obturator internus and tibialis posterior in the lower limbs and subscapularis, spinati, sternocleidomastoid and levator scapulae in the upper girdle were the most spared. Asymmetry and STIR hyperintensities were consistent features. The pattern of muscle involvement was similar to that of FSHD1, and the combined involvement of trapezius, abdominal and hamstring muscles, together with complete sparing of iliopsoas and subscapularis, was detected in 91% of patients. Peculiar differences were identified in a rostro‐caudal gradient, a predominant involvement of lower limb muscles compared to the upper girdle, and in the higher percentage of STIR hyperintensities in FSHD2.
Conclusion
This multicentre study defines the pattern of muscle involvement in FSHD2, providing useful information for diagnostics and clinical trial design. Both similarities and differences between FSHD1 and FSHD2 were detected, which is also relevant to better understand the pathogenic mechanisms underlying the FSHD‐related disease spectrum. |
doi_str_mv | 10.1111/ene.14446 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2426535864</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2458467735</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3536-dd37ce869fd0a5e5240d7d22489bc38309347aa3d4a00507a7b4fde8a1e234533</originalsourceid><addsrcrecordid>eNp1kMtKxDAUhoMoXkYXvoAE3OiiTu7pLEXHCwy60XXIJKdOpW1qMkX69kZHXQieTQ7hy8efH6FjSi5onil0cEGFEGoL7VOhyoJyTrfzziUtJCV0Dx2k9EoIYZqRXbTHmZrpUvF9ZK4BetyvoAvrsa-7FxwqXFlXh-RsPzRhNbQQbYPbIbmhsRH7Ma1j6Fcjzg8AM7wccWtfOljXDkdIobOdA1znu6w7RDuVbRIcfZ8T9Hwzf7q6KxaPt_dXl4vCcclV4T3XDko1qzyxEiQTxGvPmChnS8dLTmZcaGu5F5YQSbTVS1F5KC0FxoXkfILONt4-hrcB0tq0dXLQNLaDMCTDBFOSy1KJjJ7-QV_DELucLlOyFErrnGmCzjeUiyGlCJXpY_5THA0l5rN1k1s3X61n9uTbOCxb8L_kT80ZmG6A97qB8X-TmT_MN8oP7RCLtQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2458467735</pqid></control><display><type>article</type><title>Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging</title><source>Wiley Journals</source><creator>Giacomucci, G. ; Monforte, M. ; Diaz‐Manera, J. ; Mul, K. ; Fernandez Torrón, R. ; Maggi, L. ; Marini Bettolo, C. ; Dahlqvist, J. R. ; Haberlova, J. ; Camaño, P. ; Gros, M. ; Tartaglione, T. ; Cristiano, L. ; Gerevini, S. ; Calandra, P. ; Deidda, G. ; Giardina, E. ; Sacconi, S. ; Straub, V. ; Vissing, J. ; Van Engelen, B. ; Ricci, E. ; Tasca, G.</creator><creatorcontrib>Giacomucci, G. ; Monforte, M. ; Diaz‐Manera, J. ; Mul, K. ; Fernandez Torrón, R. ; Maggi, L. ; Marini Bettolo, C. ; Dahlqvist, J. R. ; Haberlova, J. ; Camaño, P. ; Gros, M. ; Tartaglione, T. ; Cristiano, L. ; Gerevini, S. ; Calandra, P. ; Deidda, G. ; Giardina, E. ; Sacconi, S. ; Straub, V. ; Vissing, J. ; Van Engelen, B. ; Ricci, E. ; Tasca, G.</creatorcontrib><description>Background and purpose
The aim was to define the radiological picture of facioscapulohumeral muscular dystrophy 2 (FSHD2) in comparison with FSHD1 and to explore correlations between imaging and clinical/molecular data.
Methods
Upper girdle and/or lower limb muscle magnetic resonance imaging scans of 34 molecularly confirmed FSHD2 patients from nine European neuromuscular centres were analysed. T1‐weighted and short‐tau inversion recovery (STIR) sequences were used to evaluate the global pattern and to assess the extent of fatty replacement and muscle oedema.
Results
The most frequently affected muscles were obliquus and transversus abdominis, semimembranosus, soleus and gluteus minimus in the lower limbs; trapezius, serratus anterior, latissimus dorsi and pectoralis major in the upper girdle. Iliopsoas, popliteus, obturator internus and tibialis posterior in the lower limbs and subscapularis, spinati, sternocleidomastoid and levator scapulae in the upper girdle were the most spared. Asymmetry and STIR hyperintensities were consistent features. The pattern of muscle involvement was similar to that of FSHD1, and the combined involvement of trapezius, abdominal and hamstring muscles, together with complete sparing of iliopsoas and subscapularis, was detected in 91% of patients. Peculiar differences were identified in a rostro‐caudal gradient, a predominant involvement of lower limb muscles compared to the upper girdle, and in the higher percentage of STIR hyperintensities in FSHD2.
Conclusion
This multicentre study defines the pattern of muscle involvement in FSHD2, providing useful information for diagnostics and clinical trial design. Both similarities and differences between FSHD1 and FSHD2 were detected, which is also relevant to better understand the pathogenic mechanisms underlying the FSHD‐related disease spectrum.</description><identifier>ISSN: 1351-5101</identifier><identifier>EISSN: 1468-1331</identifier><identifier>DOI: 10.1111/ene.14446</identifier><identifier>PMID: 32697863</identifier><language>eng</language><publisher>England: John Wiley & Sons, Inc</publisher><subject>Dystrophy ; Edema ; facioscapulohumeral muscular dystrophy ; FSHD ; FSHD2 ; Limbs ; Magnetic resonance imaging ; Medical imaging ; muscle MRI ; Muscles ; Muscular dystrophy ; neuromuscular diseases ; Phenotyping ; Resonance ; Tau protein</subject><ispartof>European journal of neurology, 2020-12, Vol.27 (12), p.2604-2615</ispartof><rights>2020 European Academy of Neurology</rights><rights>2020 European Academy of Neurology.</rights><rights>Copyright © 2020 European Academy of Neurology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3536-dd37ce869fd0a5e5240d7d22489bc38309347aa3d4a00507a7b4fde8a1e234533</citedby><cites>FETCH-LOGICAL-c3536-dd37ce869fd0a5e5240d7d22489bc38309347aa3d4a00507a7b4fde8a1e234533</cites><orcidid>0000-0001-9867-9047 ; 0000-0001-6144-8544 ; 0000-0003-2941-7988 ; 0000-0002-4327-6969 ; 0000-0003-3092-3597 ; 0000-0002-8711-331X ; 0000-0002-0828-5800 ; 0000-0001-8487-9478 ; 0000-0002-2741-5009 ; 0000-0002-4116-5579 ; 0000-0002-3149-1661 ; 0000-0002-0246-1455 ; 0000-0003-3896-4078 ; 0000-0001-6948-876X ; 0000-0002-2374-194X ; 0000-0003-0849-9144 ; 0000-0001-9046-3540 ; 0000-0002-2202-8165</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fene.14446$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fene.14446$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32697863$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Giacomucci, G.</creatorcontrib><creatorcontrib>Monforte, M.</creatorcontrib><creatorcontrib>Diaz‐Manera, J.</creatorcontrib><creatorcontrib>Mul, K.</creatorcontrib><creatorcontrib>Fernandez Torrón, R.</creatorcontrib><creatorcontrib>Maggi, L.</creatorcontrib><creatorcontrib>Marini Bettolo, C.</creatorcontrib><creatorcontrib>Dahlqvist, J. R.</creatorcontrib><creatorcontrib>Haberlova, J.</creatorcontrib><creatorcontrib>Camaño, P.</creatorcontrib><creatorcontrib>Gros, M.</creatorcontrib><creatorcontrib>Tartaglione, T.</creatorcontrib><creatorcontrib>Cristiano, L.</creatorcontrib><creatorcontrib>Gerevini, S.</creatorcontrib><creatorcontrib>Calandra, P.</creatorcontrib><creatorcontrib>Deidda, G.</creatorcontrib><creatorcontrib>Giardina, E.</creatorcontrib><creatorcontrib>Sacconi, S.</creatorcontrib><creatorcontrib>Straub, V.</creatorcontrib><creatorcontrib>Vissing, J.</creatorcontrib><creatorcontrib>Van Engelen, B.</creatorcontrib><creatorcontrib>Ricci, E.</creatorcontrib><creatorcontrib>Tasca, G.</creatorcontrib><title>Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging</title><title>European journal of neurology</title><addtitle>Eur J Neurol</addtitle><description>Background and purpose
The aim was to define the radiological picture of facioscapulohumeral muscular dystrophy 2 (FSHD2) in comparison with FSHD1 and to explore correlations between imaging and clinical/molecular data.
Methods
Upper girdle and/or lower limb muscle magnetic resonance imaging scans of 34 molecularly confirmed FSHD2 patients from nine European neuromuscular centres were analysed. T1‐weighted and short‐tau inversion recovery (STIR) sequences were used to evaluate the global pattern and to assess the extent of fatty replacement and muscle oedema.
Results
The most frequently affected muscles were obliquus and transversus abdominis, semimembranosus, soleus and gluteus minimus in the lower limbs; trapezius, serratus anterior, latissimus dorsi and pectoralis major in the upper girdle. Iliopsoas, popliteus, obturator internus and tibialis posterior in the lower limbs and subscapularis, spinati, sternocleidomastoid and levator scapulae in the upper girdle were the most spared. Asymmetry and STIR hyperintensities were consistent features. The pattern of muscle involvement was similar to that of FSHD1, and the combined involvement of trapezius, abdominal and hamstring muscles, together with complete sparing of iliopsoas and subscapularis, was detected in 91% of patients. Peculiar differences were identified in a rostro‐caudal gradient, a predominant involvement of lower limb muscles compared to the upper girdle, and in the higher percentage of STIR hyperintensities in FSHD2.
Conclusion
This multicentre study defines the pattern of muscle involvement in FSHD2, providing useful information for diagnostics and clinical trial design. Both similarities and differences between FSHD1 and FSHD2 were detected, which is also relevant to better understand the pathogenic mechanisms underlying the FSHD‐related disease spectrum.</description><subject>Dystrophy</subject><subject>Edema</subject><subject>facioscapulohumeral muscular dystrophy</subject><subject>FSHD</subject><subject>FSHD2</subject><subject>Limbs</subject><subject>Magnetic resonance imaging</subject><subject>Medical imaging</subject><subject>muscle MRI</subject><subject>Muscles</subject><subject>Muscular dystrophy</subject><subject>neuromuscular diseases</subject><subject>Phenotyping</subject><subject>Resonance</subject><subject>Tau protein</subject><issn>1351-5101</issn><issn>1468-1331</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp1kMtKxDAUhoMoXkYXvoAE3OiiTu7pLEXHCwy60XXIJKdOpW1qMkX69kZHXQieTQ7hy8efH6FjSi5onil0cEGFEGoL7VOhyoJyTrfzziUtJCV0Dx2k9EoIYZqRXbTHmZrpUvF9ZK4BetyvoAvrsa-7FxwqXFlXh-RsPzRhNbQQbYPbIbmhsRH7Ma1j6Fcjzg8AM7wccWtfOljXDkdIobOdA1znu6w7RDuVbRIcfZ8T9Hwzf7q6KxaPt_dXl4vCcclV4T3XDko1qzyxEiQTxGvPmChnS8dLTmZcaGu5F5YQSbTVS1F5KC0FxoXkfILONt4-hrcB0tq0dXLQNLaDMCTDBFOSy1KJjJ7-QV_DELucLlOyFErrnGmCzjeUiyGlCJXpY_5THA0l5rN1k1s3X61n9uTbOCxb8L_kT80ZmG6A97qB8X-TmT_MN8oP7RCLtQ</recordid><startdate>202012</startdate><enddate>202012</enddate><creator>Giacomucci, G.</creator><creator>Monforte, M.</creator><creator>Diaz‐Manera, J.</creator><creator>Mul, K.</creator><creator>Fernandez Torrón, R.</creator><creator>Maggi, L.</creator><creator>Marini Bettolo, C.</creator><creator>Dahlqvist, J. R.</creator><creator>Haberlova, J.</creator><creator>Camaño, P.</creator><creator>Gros, M.</creator><creator>Tartaglione, T.</creator><creator>Cristiano, L.</creator><creator>Gerevini, S.</creator><creator>Calandra, P.</creator><creator>Deidda, G.</creator><creator>Giardina, E.</creator><creator>Sacconi, S.</creator><creator>Straub, V.</creator><creator>Vissing, J.</creator><creator>Van Engelen, B.</creator><creator>Ricci, E.</creator><creator>Tasca, G.</creator><general>John Wiley & Sons, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9867-9047</orcidid><orcidid>https://orcid.org/0000-0001-6144-8544</orcidid><orcidid>https://orcid.org/0000-0003-2941-7988</orcidid><orcidid>https://orcid.org/0000-0002-4327-6969</orcidid><orcidid>https://orcid.org/0000-0003-3092-3597</orcidid><orcidid>https://orcid.org/0000-0002-8711-331X</orcidid><orcidid>https://orcid.org/0000-0002-0828-5800</orcidid><orcidid>https://orcid.org/0000-0001-8487-9478</orcidid><orcidid>https://orcid.org/0000-0002-2741-5009</orcidid><orcidid>https://orcid.org/0000-0002-4116-5579</orcidid><orcidid>https://orcid.org/0000-0002-3149-1661</orcidid><orcidid>https://orcid.org/0000-0002-0246-1455</orcidid><orcidid>https://orcid.org/0000-0003-3896-4078</orcidid><orcidid>https://orcid.org/0000-0001-6948-876X</orcidid><orcidid>https://orcid.org/0000-0002-2374-194X</orcidid><orcidid>https://orcid.org/0000-0003-0849-9144</orcidid><orcidid>https://orcid.org/0000-0001-9046-3540</orcidid><orcidid>https://orcid.org/0000-0002-2202-8165</orcidid></search><sort><creationdate>202012</creationdate><title>Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging</title><author>Giacomucci, G. ; Monforte, M. ; Diaz‐Manera, J. ; Mul, K. ; Fernandez Torrón, R. ; Maggi, L. ; Marini Bettolo, C. ; Dahlqvist, J. R. ; Haberlova, J. ; Camaño, P. ; Gros, M. ; Tartaglione, T. ; Cristiano, L. ; Gerevini, S. ; Calandra, P. ; Deidda, G. ; Giardina, E. ; Sacconi, S. ; Straub, V. ; Vissing, J. ; Van Engelen, B. ; Ricci, E. ; Tasca, G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3536-dd37ce869fd0a5e5240d7d22489bc38309347aa3d4a00507a7b4fde8a1e234533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Dystrophy</topic><topic>Edema</topic><topic>facioscapulohumeral muscular dystrophy</topic><topic>FSHD</topic><topic>FSHD2</topic><topic>Limbs</topic><topic>Magnetic resonance imaging</topic><topic>Medical imaging</topic><topic>muscle MRI</topic><topic>Muscles</topic><topic>Muscular dystrophy</topic><topic>neuromuscular diseases</topic><topic>Phenotyping</topic><topic>Resonance</topic><topic>Tau protein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Giacomucci, G.</creatorcontrib><creatorcontrib>Monforte, M.</creatorcontrib><creatorcontrib>Diaz‐Manera, J.</creatorcontrib><creatorcontrib>Mul, K.</creatorcontrib><creatorcontrib>Fernandez Torrón, R.</creatorcontrib><creatorcontrib>Maggi, L.</creatorcontrib><creatorcontrib>Marini Bettolo, C.</creatorcontrib><creatorcontrib>Dahlqvist, J. R.</creatorcontrib><creatorcontrib>Haberlova, J.</creatorcontrib><creatorcontrib>Camaño, P.</creatorcontrib><creatorcontrib>Gros, M.</creatorcontrib><creatorcontrib>Tartaglione, T.</creatorcontrib><creatorcontrib>Cristiano, L.</creatorcontrib><creatorcontrib>Gerevini, S.</creatorcontrib><creatorcontrib>Calandra, P.</creatorcontrib><creatorcontrib>Deidda, G.</creatorcontrib><creatorcontrib>Giardina, E.</creatorcontrib><creatorcontrib>Sacconi, S.</creatorcontrib><creatorcontrib>Straub, V.</creatorcontrib><creatorcontrib>Vissing, J.</creatorcontrib><creatorcontrib>Van Engelen, B.</creatorcontrib><creatorcontrib>Ricci, E.</creatorcontrib><creatorcontrib>Tasca, G.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Giacomucci, G.</au><au>Monforte, M.</au><au>Diaz‐Manera, J.</au><au>Mul, K.</au><au>Fernandez Torrón, R.</au><au>Maggi, L.</au><au>Marini Bettolo, C.</au><au>Dahlqvist, J. R.</au><au>Haberlova, J.</au><au>Camaño, P.</au><au>Gros, M.</au><au>Tartaglione, T.</au><au>Cristiano, L.</au><au>Gerevini, S.</au><au>Calandra, P.</au><au>Deidda, G.</au><au>Giardina, E.</au><au>Sacconi, S.</au><au>Straub, V.</au><au>Vissing, J.</au><au>Van Engelen, B.</au><au>Ricci, E.</au><au>Tasca, G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging</atitle><jtitle>European journal of neurology</jtitle><addtitle>Eur J Neurol</addtitle><date>2020-12</date><risdate>2020</risdate><volume>27</volume><issue>12</issue><spage>2604</spage><epage>2615</epage><pages>2604-2615</pages><issn>1351-5101</issn><eissn>1468-1331</eissn><abstract>Background and purpose
The aim was to define the radiological picture of facioscapulohumeral muscular dystrophy 2 (FSHD2) in comparison with FSHD1 and to explore correlations between imaging and clinical/molecular data.
Methods
Upper girdle and/or lower limb muscle magnetic resonance imaging scans of 34 molecularly confirmed FSHD2 patients from nine European neuromuscular centres were analysed. T1‐weighted and short‐tau inversion recovery (STIR) sequences were used to evaluate the global pattern and to assess the extent of fatty replacement and muscle oedema.
Results
The most frequently affected muscles were obliquus and transversus abdominis, semimembranosus, soleus and gluteus minimus in the lower limbs; trapezius, serratus anterior, latissimus dorsi and pectoralis major in the upper girdle. Iliopsoas, popliteus, obturator internus and tibialis posterior in the lower limbs and subscapularis, spinati, sternocleidomastoid and levator scapulae in the upper girdle were the most spared. Asymmetry and STIR hyperintensities were consistent features. The pattern of muscle involvement was similar to that of FSHD1, and the combined involvement of trapezius, abdominal and hamstring muscles, together with complete sparing of iliopsoas and subscapularis, was detected in 91% of patients. Peculiar differences were identified in a rostro‐caudal gradient, a predominant involvement of lower limb muscles compared to the upper girdle, and in the higher percentage of STIR hyperintensities in FSHD2.
Conclusion
This multicentre study defines the pattern of muscle involvement in FSHD2, providing useful information for diagnostics and clinical trial design. Both similarities and differences between FSHD1 and FSHD2 were detected, which is also relevant to better understand the pathogenic mechanisms underlying the FSHD‐related disease spectrum.</abstract><cop>England</cop><pub>John Wiley & Sons, Inc</pub><pmid>32697863</pmid><doi>10.1111/ene.14446</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0001-9867-9047</orcidid><orcidid>https://orcid.org/0000-0001-6144-8544</orcidid><orcidid>https://orcid.org/0000-0003-2941-7988</orcidid><orcidid>https://orcid.org/0000-0002-4327-6969</orcidid><orcidid>https://orcid.org/0000-0003-3092-3597</orcidid><orcidid>https://orcid.org/0000-0002-8711-331X</orcidid><orcidid>https://orcid.org/0000-0002-0828-5800</orcidid><orcidid>https://orcid.org/0000-0001-8487-9478</orcidid><orcidid>https://orcid.org/0000-0002-2741-5009</orcidid><orcidid>https://orcid.org/0000-0002-4116-5579</orcidid><orcidid>https://orcid.org/0000-0002-3149-1661</orcidid><orcidid>https://orcid.org/0000-0002-0246-1455</orcidid><orcidid>https://orcid.org/0000-0003-3896-4078</orcidid><orcidid>https://orcid.org/0000-0001-6948-876X</orcidid><orcidid>https://orcid.org/0000-0002-2374-194X</orcidid><orcidid>https://orcid.org/0000-0003-0849-9144</orcidid><orcidid>https://orcid.org/0000-0001-9046-3540</orcidid><orcidid>https://orcid.org/0000-0002-2202-8165</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1351-5101 |
ispartof | European journal of neurology, 2020-12, Vol.27 (12), p.2604-2615 |
issn | 1351-5101 1468-1331 |
language | eng |
recordid | cdi_proquest_miscellaneous_2426535864 |
source | Wiley Journals |
subjects | Dystrophy Edema facioscapulohumeral muscular dystrophy FSHD FSHD2 Limbs Magnetic resonance imaging Medical imaging muscle MRI Muscles Muscular dystrophy neuromuscular diseases Phenotyping Resonance Tau protein |
title | Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T15%3A53%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Deep%20phenotyping%20of%20facioscapulohumeral%20muscular%20dystrophy%20type%202%20by%20magnetic%20resonance%20imaging&rft.jtitle=European%20journal%20of%20neurology&rft.au=Giacomucci,%20G.&rft.date=2020-12&rft.volume=27&rft.issue=12&rft.spage=2604&rft.epage=2615&rft.pages=2604-2615&rft.issn=1351-5101&rft.eissn=1468-1331&rft_id=info:doi/10.1111/ene.14446&rft_dat=%3Cproquest_cross%3E2458467735%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2458467735&rft_id=info:pmid/32697863&rfr_iscdi=true |